Cholesterol Goal Attainment Rate and Its Associated Factors Among Dyslipidemic Patients on Lipid-lowering Drug Therapy in Korea (CRESENDO)

AstraZeneca

Status: Completed

Conditions: Dyslipidemia

Study type: Observational

Funder types: Industry

Identifiers

NCT01372956

NIS-CKR-XXX-2011/1

Details and patient eligibility

About

This is a multi-centre, cross-sectional, chart review study to investigate cholesterol goal attainment rates defined by modified NCEP-ATP III guidelines and define its possible determinants among Korean dyslipidemic patients

Full description

MC MD

Enrollment: 4,950 patients

Sex: All

Ages: 19+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patient who has a dyslipidemia with a lipid profile result within 3 months
• Patient who has a dyslipidemia without change of lipid lowering drug dosage during 3 months after lipid profile test.

Exclusion criteria

• Patient who involved in this study previously.
• Patient who participated in other clinical study with study drug within 90 days.

Trial design

4,950 participants in 1 patient group

Dyslipidemia